Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the complete record of transactions filed by Baird William D III, Director Financiero. Director active across 3 companies, notably bluebird bio, Inc.. In total, 26 filings have been recorded. Split: 0 buy · 14 sells. Total volume traded: €510k. Activity tracked since 2 August 2021. The latest transaction was filed on 17 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Baird William D III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Baird William D III is Chief Financial Officer and has 26 filings in total. Across the 26 sampled recent filings, the activity is sell-side, with no reported purchases and 509841 EUR of sales between 2016-01-06 and 2025-05-15. The recent filings relate to 2seventy bio, Inc., bluebird bio, Inc. and AMICUS THERAPEUTICS INC, and the main reported sales are 118974.3936293977 EUR on 2024-01-05, 90688.56371062718 EUR on 2025-01-07, 65767.66972199638 EUR on 2022-08-08, 56200.14804859565 EUR on 2022-07-19, 38628.27731023482 EUR on 2023-08-07, and 35564.37192909666 EUR on 2023-08-24, all at 2seventy bio, Inc.